{"product_id":"braunol","title":"Braunol Povidone Iodine Antiseptic Solution for Skin Mucosa and Wounds","description":"\u003cdiv id=\"ai-summary\" style=\"background:#f8f9fa;border-left:4px solid #0057a8;padding:12px 16px;margin-bottom:20px;\"\u003e\n  \u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Braunol (B. Braun, povidone-iodine 7.5% w\/w aqueous solution, equivalent to 0.75% available iodine) is a broad-spectrum antiseptic for intact and damaged skin, mucous membranes, and wounds, with documented bactericidal, fungicidal, mycobactericidal, virucidal, and protozoal activity. Its onset of action is approximately 15–30 seconds with sustained brown staining indicating active drug presence on the skin. Indicated for surgical site preparation, mucous membrane antisepsis, and wound antisepsis. CE marked under EU MDR 2017\/745; manufactured under ISO 13485; HSA Singapore registered.\n\u003c\/div\u003e\n\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eBraunol is an aqueous antiseptic solution containing 7.5% povidone-iodine (PVP-I) corresponding to approximately 0.75% available iodine. It is supplied ready-to-use and may also be diluted with sterile water or saline for mucous membrane indications. Iodine is released slowly from the polyvinylpyrrolidone (povidone) carrier complex on contact with skin or wound tissue, providing rapid microbicidal activity with reduced cytotoxicity compared with aqueous iodine tincture, and lower allergenicity than chlorhexidine in iodine-tolerant patients.\u003c\/p\u003e\n\u003cp\u003eBraunol is the German B. Braun reference product widely used in European operating theatres for skin disinfection prior to surgical incision, regional and central venous catheter insertion, mucosal antisepsis prior to oral, vaginal, urological, and ENT procedures, and antiseptic irrigation of acute and chronic wounds (per WHO Guidelines for Safe Surgery 2009 and recent EWMA position documents on antiseptic stewardship).\u003c\/p\u003e\n\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eB. Braun Melsungen AG (Germany)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePovidone-iodine 7.5% w\/w (approximately 0.75% available iodine)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eExcipients\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGlycerol, disodium hydrogen phosphate dihydrate, citric acid monohydrate, sodium hydroxide, nonoxinol, purified water\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDark red-brown aqueous solution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003epH\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eApproximately 1.5 to 6.5 (formulation dependent)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOnset of Action\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e~15 to 30 seconds (bactericidal); 1 minute (virucidal\/fungicidal per EN 13727, EN 14476)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSpectrum\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBactericidal (incl. MRSA, VRE), fungicidal (Candida), mycobactericidal, virucidal (incl. HBV, HCV, HIV, SARS-CoV-2), protozoal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIndications\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSkin antisepsis, surgical site preparation, mucous membrane antisepsis, wound antisepsis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eContraindications\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIodine hypersensitivity, hyperthyroidism, dermatitis herpetiformis Duhring; caution in neonates, pregnancy, lactation, large surface burns, lithium therapy, thyroid scintigraphy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCE marked under EU MDR 2017\/745; ISO 13485 manufactured; HSA Singapore registered medical product; conforms to EN 1500, EN 13727, EN 13624, EN 14476 efficacy standards\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30 ml, 100 ml, 250 ml, 500 ml, 1000 ml bottles (variant dependent)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eShelf Life\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e3 years unopened; use within 24 months after first opening\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStore below 25 degrees Celsius, protected from light, do not freeze\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eClinical Indications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePre-operative skin antisepsis at surgical site (WHO Guidelines for Safe Surgery 2009; CDC\/HICPAC SSI prevention)\u003c\/li\u003e\n\u003cli\u003eAntisepsis prior to central venous, peripheral, and arterial catheter insertion (CDC HICPAC catheter-related infection prevention; alternative to chlorhexidine in chlorhexidine-sensitive patients)\u003c\/li\u003e\n\u003cli\u003eMucous membrane antisepsis for oral, vaginal, urological, ENT, and ophthalmic preparation procedures (diluted as per IFU)\u003c\/li\u003e\n\u003cli\u003eAcute traumatic wound and burn wound cleansing where iodophor antisepsis is preferred\u003c\/li\u003e\n\u003cli\u003eChronic wound antisepsis under EWMA antiseptic stewardship principles, time-limited courses with clinical reassessment\u003c\/li\u003e\n\u003cli\u003ePre-injection skin antisepsis where alcohol or chlorhexidine is contraindicated\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the difference between Braunol 7.5% and an alcohol-based PVP-I (e.g. Betadine alcoholic solution)?\u003c\/strong\u003e\u003cbr\u003eA: Braunol is an aqueous PVP-I solution suitable for skin, mucous membranes, and open wounds. Alcoholic PVP-I solutions provide faster onset and longer residual activity for intact-skin surgical-site antisepsis but are contraindicated on mucosa, open wounds, and electrocautery sites due to flammability and tissue irritation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can Braunol be used on chronic wounds long term?\u003c\/strong\u003e\u003cbr\u003eA: Per EWMA antiseptic stewardship guidance and Cochrane evidence reviews, antiseptic exposure on chronic wounds should be time-limited (typically 1–2 weeks), with clinical reassessment to avoid cytotoxicity and to limit selection pressure on local microflora. Braunol is appropriate for short antiseptic courses where biofilm or bioburden management is required.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does Braunol interfere with thyroid function?\u003c\/strong\u003e\u003cbr\u003eA: Repeated, large-area, or prolonged use can transiently affect thyroid function due to systemic iodine absorption. Braunol is contraindicated in manifest hyperthyroidism and used with caution in neonates, pregnancy, lactation, and patients on lithium or scheduled thyroid scintigraphy. Thyroid function monitoring is appropriate after extensive paediatric burn antisepsis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is Braunol the same as Betadine in Singapore practice?\u003c\/strong\u003e\u003cbr\u003eA: Both are povidone-iodine 7.5–10% antiseptics. Braunol is the B. Braun German PVP-I formulation, registered with HSA Singapore, and frequently chosen by Singapore restructured hospitals and surgical day centres for its consistent batch quality and EN-tested efficacy data. Betadine is the Mundipharma brand. Substitution between brands is acceptable for most antiseptic indications.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is HSA registration required for clinical purchase in Singapore?\u003c\/strong\u003e\u003cbr\u003eA: Braunol is HSA-registered and routinely procured by Singapore restructured hospitals, polyclinics, surgical centres, day procedure clinics, and home-care providers. EMIS+ supplies the genuine B. Braun product with full lot traceability for institutional procurement and B2B clinic accounts.\u003c\/p\u003e","brand":"B. Braun","offers":[{"title":"Default Title","offer_id":43239230210126,"sku":"SG-B-2498-B","price":5.7,"currency_code":"SGD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/Braunol_Povidone_Iodine_Antiseptic_Solution_1.png?v=1766957345","url":"https:\/\/www.emis.asia\/zh\/products\/braunol","provider":"EMIS +","version":"1.0","type":"link"}